[go: up one dir, main page]

AU2001272615A1 - Amphipathic linear peptides and compositions containing same - Google Patents

Amphipathic linear peptides and compositions containing same

Info

Publication number
AU2001272615A1
AU2001272615A1 AU2001272615A AU7261501A AU2001272615A1 AU 2001272615 A1 AU2001272615 A1 AU 2001272615A1 AU 2001272615 A AU2001272615 A AU 2001272615A AU 7261501 A AU7261501 A AU 7261501A AU 2001272615 A1 AU2001272615 A1 AU 2001272615A1
Authority
AU
Australia
Prior art keywords
compositions containing
containing same
linear peptides
amphipathic linear
amphipathic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272615A
Inventor
Guillaume Drin
Jerome Gomar
Anthony R. Rees
Jamal Temsamani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synt EM SA
Original Assignee
Synt EM SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synt EM SA filed Critical Synt EM SA
Publication of AU2001272615A1 publication Critical patent/AU2001272615A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001272615A 2000-07-03 2001-07-03 Amphipathic linear peptides and compositions containing same Abandoned AU2001272615A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0008633A FR2810985B1 (en) 2000-07-03 2000-07-03 AMPHIPATHIC LINEAR PEPTIDES AND COMPOSITIONS CONTAINING THEM
FR0008633 2000-07-03
PCT/FR2001/002129 WO2002002595A1 (en) 2000-07-03 2001-07-03 Amphipathic linear peptides and compositions containing same

Publications (1)

Publication Number Publication Date
AU2001272615A1 true AU2001272615A1 (en) 2002-01-14

Family

ID=8852054

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272615A Abandoned AU2001272615A1 (en) 2000-07-03 2001-07-03 Amphipathic linear peptides and compositions containing same

Country Status (8)

Country Link
US (1) US20030186890A1 (en)
EP (1) EP1297001A1 (en)
JP (1) JP2004517039A (en)
AU (1) AU2001272615A1 (en)
CA (1) CA2414355A1 (en)
FR (1) FR2810985B1 (en)
IL (1) IL153671A0 (en)
WO (1) WO2002002595A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2830016B1 (en) * 2001-09-27 2004-06-25 Synt Em COMPOSITIONS FOR THE VECTORIZATION OF TAXOID DERIVATIVES THROUGH THE HEMATOENCEPHALIC BARRIER AND THEIR USE FOR THE TREATMENT OF CANCERS, PARTICULARLY BRAIN CANCERS
FR2829940A1 (en) * 2001-09-27 2003-03-28 Synt Em New composition, useful for treating central nervous system diseases, comprises an antibody linked to a linear peptide and is able to cross the blood-brain barrier
US7314626B2 (en) 2001-10-16 2008-01-01 Synt:Em S.A. Use of peptide vectors to improve the immune response to antigens
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
FR2840810B1 (en) * 2002-06-18 2005-02-11 Synt Em COMPOSITION FOR THE TRANSFER OF THERAPEUTIC MOLECULES TO LUNGS AND THEIR USE IN THE TREATMENT OF LUNG CANCERS AND PULMONARY DISEASES
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof
FR2865735B1 (en) * 2004-02-02 2006-08-11 Synt Em INHIBITORS OF ANGIOGENESIS, COMPOSITIONS CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEREGULATION OF ANGIOGENESIS
FR2865736B1 (en) * 2004-02-02 2006-07-14 Synt Em INHIBITORS OF ANGIOGENESIS, COMPOSITIONS CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEREGULATION OF ANGIOGENESIS
CA2607095A1 (en) 2005-05-05 2006-11-09 Centre For Addiction And Mental Health Compositions and methods for modulating dopamine neurotransmission
JP5313867B2 (en) 2006-03-30 2013-10-09 ドライス ファーマシューティカルズ，インコーポレイティド Camptothecin-cell penetrating peptide complex and pharmaceutical composition containing the same
GB0715809D0 (en) * 2007-08-14 2007-09-26 Univ Leuven Kath Alpha synuclein toxicity
WO2009149560A1 (en) 2008-06-12 2009-12-17 Centre For Addiction And Mental Health Compositions and methods for modulating d1-d2 dopamine receptor interaction and function
CA2727141A1 (en) * 2008-06-13 2009-12-17 Centre For Addiction And Mental Health Compositions and methods for modulating nicotinic/nmda receptor function
FR2941230B1 (en) * 2009-01-19 2011-03-18 Centre Nat Rech Scient ADDRESSING POLYPEPTIDES SPECIFIC TO OTX2 TARGET CELLS
WO2011050152A2 (en) * 2009-10-21 2011-04-28 The Johns Hopkins University Site-specific modification of proteins
WO2022094614A1 (en) * 2020-10-29 2022-05-05 The Regents Of The University Of California Anti-dpp6 chimeric antigen receptor bearing regulatory t cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
US5580852A (en) * 1993-12-17 1996-12-03 Pioneer Hi-Bred International, Inc. Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
FR2767323B1 (en) * 1997-08-12 2001-01-05 Synt Em LINEAR PEPTIDES DERIVED FROM ANTIBIOTIC PEPTIDES, THEIR PREPARATION AND THEIR USE FOR VECTORIZING ACTIVE SUBSTANCES
US6015941A (en) * 1997-10-31 2000-01-18 Pioneer Hi-Bred International, Inc. Peptide derivatives of tachyplesin having antimicrobial activity

Also Published As

Publication number Publication date
WO2002002595A9 (en) 2002-03-28
FR2810985A1 (en) 2002-01-04
FR2810985B1 (en) 2004-12-24
CA2414355A1 (en) 2002-01-10
WO2002002595A1 (en) 2002-01-10
IL153671A0 (en) 2003-07-06
JP2004517039A (en) 2004-06-10
EP1297001A1 (en) 2003-04-02
US20030186890A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001272615A1 (en) Amphipathic linear peptides and compositions containing same
AU2001293728A1 (en) Cosmetic composition
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU6179600A (en) Peptides and pharmaceutical compositions comprising same
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU4876701A (en) Peptide derivatives and medicinal compositions
AU2001296389A1 (en) Stable peptide formulations
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2002227928A1 (en) Cosmetic composition
AU2001294374A1 (en) 2-acylindenes and these containing perfume compositions
IL135442A0 (en) Peptides and pharmaceutical compositions comprising them
GB0014208D0 (en) Protein and compositions containing it
GB0014204D0 (en) Protein and compositions containing it
GB0014211D0 (en) Protein and compositions containing it
GB0014212D0 (en) Protein and compositions containing it
GB0014214D0 (en) Protein and compositions containing it
GB0018771D0 (en) Protein and compositions containing it
GB0014207D0 (en) Protein and compositions containing it
GB0014196D0 (en) Protein and compositions containing it
GB0014206D0 (en) Protein and compositions containing it
GB0014209D0 (en) Protein and compositions containing it
GB0014203D0 (en) Protein and compositions containing it
GB0014202D0 (en) Protein and compositions containing it